Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns

NCT04463758 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3060

Last updated 2021-10-04

No results posted yet for this study

Summary

The purpose of this study is to characterize the incidence and clinical features of the maternal COVID 19 infection, as well as the associated morbidity of the mother and the child, in the French context

Conditions

  • covid19 Infection
  • Pregnancy Complications
  • Neonatal Complications

Interventions

OTHER

An auto-questionnaire comprising three psychometric scales

three psychometric scales validated in French: \_depression (Edinburgh Postpartum Depression Scale (EPDS)), anxiety (State-Trait Anxiety Inventory (STAI) \- and Impact of Event Scale (Revised) (IES-R)

Sponsors & Collaborators

  • INSERM, Epopé team

    collaborator UNKNOWN
  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Pierre Yv Ancel, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-11
Primary Completion
2022-02-28
Completion
2022-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04463758 on ClinicalTrials.gov